A pharmaceuticals health care company.
Payments issues related to transcatheter mitral valve repair procedures in the Medicare IPPS Final Rule for FY 2015.
H.R. 2925: Strengthening Medicare Anti-Fraud Measures Act of 2013.
Education about federal regulations related to "anti-switching" rules which prohibit contract suppliers from incentivizing Medicare beneficiaries to switch their current blood glucose monitor. Monitored legislative efforts to reform the corporate tax system.
H.R.4438: American Research and Competitiveness Act of 2014.
S.2360/H.R. 4679: Stop Corporate Inversions Act of 2014. H.R. 4432: Safe and Accurate Food Labeling Act of 2014.
Educated staff about FDA guidances, specifically with respect to glucose meters and certain medical foods.
Educated staff about FDA interim final rule dealing with infant formulas.
FDA draft guidance related to regulatory oversight of lab developed tests.Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX